25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

BIOQ (Bioqual) Stock Analysis
Buy, Hold or Sell?

Let's analyze Bioqual together

I guess you are interested in Bioqual Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Bioqual’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Bioqual’s Price Targets

I'm going to help you getting a better view of Bioqual Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Bioqual Inc

I send you an email if I find something interesting about Bioqual Inc.

1. Quick Overview

1.1. Quick analysis of Bioqual (30 sec.)










1.2. What can you expect buying and holding a share of Bioqual? (30 sec.)

How much money do you get?

How much money do you get?
$2.00
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
$42.09
Expected worth in 1 year
$42.26
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
$2.16
Return On Investment
5.5%

For what price can you sell your share?

Current Price per Share
$39.05
Expected price per share
$0 - $43.19
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Bioqual (5 min.)




Live pricePrice per Share (EOD)
$39.05
Intrinsic Value Per Share
$55.32 - $190.31
Total Value Per Share
$97.42 - $232.40

2.2. Growth of Bioqual (5 min.)




Is Bioqual growing?

Current yearPrevious yearGrowGrow %
How rich?$37.6m$37.6m$36.2k0.1%

How much money is Bioqual making?

Current yearPrevious yearGrowGrow %
Making money$483.4k$835.5k-$352k-72.8%
Net Profit Margin0.8%1.3%--

How much money comes from the company's main activities?

2.3. Financial Health of Bioqual (5 min.)




2.4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#79 / 127

Most Revenue
#62 / 127

Most Profit
#49 / 127
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Bioqual?

Welcome investor! Bioqual's management wants to use your money to grow the business. In return you get a share of Bioqual.

First you should know what it really means to hold a share of Bioqual. And how you can make/lose money.

Speculation

The Price per Share of Bioqual is $39.05. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Bioqual.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Bioqual, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $42.09. Based on the TTM, the Book Value Change Per Share is $0.04 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.07 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.50 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Bioqual.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.541.4%0.541.4%0.932.4%2.456.3%3.839.8%3.629.3%
Usd Book Value Change Per Share0.040.1%0.040.1%-0.07-0.2%1.543.9%2.937.5%2.977.6%
Usd Dividend Per Share0.501.3%0.501.3%1.002.6%0.922.3%0.912.3%0.671.7%
Usd Total Gains Per Share0.541.4%0.541.4%0.932.4%2.456.3%3.849.8%3.659.3%
Usd Price Per Share72.50-72.50-76.00-72.83-71.92-45.23-
Price to Earnings Ratio134.12-134.12-81.35-75.79-50.31-27.50-
Price-to-Total Gains Ratio134.12-134.12-81.33-75.78-50.29-34.36-
Price to Book Ratio1.72-1.72-1.81-1.73-1.85-1.37-
Price-to-Total Gains Ratio134.12-134.12-81.33-75.78-50.29-34.36-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share39.05
Number of shares25
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.500.91
Usd Book Value Change Per Share0.042.93
Usd Total Gains Per Share0.543.84
Gains per Quarter (25 shares)13.5195.90
Gains per Year (25 shares)54.06383.61
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
15044491293374
2100898182585758
3150121522738781142
42001620636411701526
52502026045514631910
63002431454617562294
73502836863720482678
84003242272823413062
94503647681926333446
105004153091029263830

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%23.02.00.092.0%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%23.02.00.092.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%20.00.05.080.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%24.01.00.096.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Bioqual Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0410.0410%-0.065+261%1.535-97%2.926-99%2.973-99%
Book Value Per Share--42.09442.0940%42.054+0%42.089+0%39.053+8%29.999+40%
Current Ratio--4.0164.0160%3.608+11%3.625+11%3.547+13%4.569-12%
Debt To Asset Ratio--0.3350.3350%0.387-13%0.375-11%0.386-13%0.287+17%
Debt To Equity Ratio--0.5030.5030%0.630-20%0.605-17%0.633-21%0.434+16%
Dividend Per Share--0.5000.5000%1.000-50%0.917-45%0.910-45%0.675-26%
Enterprise Value--61501261.00061501261.0000%51551725.000+19%50725623.667+21%51019746.720+21%43808056.725+40%
Eps--0.5410.5410%0.934-42%2.452-78%3.832-86%3.620-85%
Ev To Ebitda Ratio--20.28220.2820%15.252+33%12.728+59%9.431+115%7.786+161%
Ev To Sales Ratio--1.0501.0500%0.823+28%0.821+28%0.886+19%0.890+18%
Free Cash Flow Per Share--9.7969.7960%6.694+46%3.793+158%2.145+357%2.230+339%
Free Cash Flow To Equity Per Share--9.2969.2960%5.694+63%2.876+223%1.235+653%1.395+567%
Gross Profit Margin--1.0001.0000%-3.740+474%-0.650+165%-0.070+107%0.444+125%
Intrinsic Value_10Y_max--190.308----------
Intrinsic Value_10Y_min--55.321----------
Intrinsic Value_1Y_max--7.103----------
Intrinsic Value_1Y_min--3.032----------
Intrinsic Value_3Y_max--30.461----------
Intrinsic Value_3Y_min--11.340----------
Intrinsic Value_5Y_max--64.816----------
Intrinsic Value_5Y_min--22.027----------
Market Cap34926944.800-86%64845160.00064845160.0000%67975616.000-5%65143462.0000%64326496.720+1%40454484.680+60%
Net Profit Margin--0.0080.0080%0.013-38%0.034-76%0.060-86%0.074-89%
Operating Margin--0.0080.0080%0.018-54%0.042-81%0.079-90%0.107-92%
Operating Ratio--1.0001.0000%0.982+2%0.961+4%0.924+8%0.895+12%
Pb Ratio0.928-86%1.7221.7220%1.807-5%1.7300%1.852-7%1.367+26%
Pe Ratio72.241-86%134.121134.1210%81.355+65%75.793+77%50.305+167%27.500+388%
Price Per Share39.050-86%72.50072.5000%76.000-5%72.8330%71.920+1%45.230+60%
Price To Free Cash Flow Ratio3.986-86%7.4017.4010%11.353-35%1.686+339%1.006+636%4.033+83%
Price To Total Gains Ratio72.241-86%134.121134.1210%81.326+65%75.783+77%50.290+167%34.364+290%
Quick Ratio--3.8503.8500%3.447+12%3.420+13%3.354+15%4.427-13%
Return On Assets--0.0090.0090%0.014-37%0.035-76%0.062-86%0.098-91%
Return On Equity--0.0130.0130%0.022-42%0.058-78%0.103-87%0.134-90%
Total Gains Per Share--0.5410.5410%0.935-42%2.452-78%3.836-86%3.648-85%
Usd Book Value--37649891.00037649891.0000%37613618.000+0%37645331.667+0%34929625.800+8%26832039.200+40%
Usd Book Value Change Per Share--0.0410.0410%-0.065+261%1.535-97%2.926-99%2.973-99%
Usd Book Value Per Share--42.09442.0940%42.054+0%42.089+0%39.053+8%29.999+40%
Usd Dividend Per Share--0.5000.5000%1.000-50%0.917-45%0.910-45%0.675-26%
Usd Enterprise Value--61501261.00061501261.0000%51551725.000+19%50725623.667+21%51019746.720+21%43808056.725+40%
Usd Eps--0.5410.5410%0.934-42%2.452-78%3.832-86%3.620-85%
Usd Free Cash Flow--8761940.0008761940.0000%5987527.000+46%3392547.333+158%1918131.600+357%1994376.600+339%
Usd Free Cash Flow Per Share--9.7969.7960%6.694+46%3.793+158%2.145+357%2.230+339%
Usd Free Cash Flow To Equity Per Share--9.2969.2960%5.694+63%2.876+223%1.235+653%1.395+567%
Usd Market Cap34926944.800-86%64845160.00064845160.0000%67975616.000-5%65143462.0000%64326496.720+1%40454484.680+60%
Usd Price Per Share39.050-86%72.50072.5000%76.000-5%72.8330%71.920+1%45.230+60%
Usd Profit--483481.000483481.0000%835548.000-42%2193199.333-78%3427472.200-86%3237822.900-85%
Usd Revenue--58590949.00058590949.0000%62663804.000-6%62468375.333-6%58289765.800+1%46541090.300+26%
Usd Total Gains Per Share--0.5410.5410%0.935-42%2.452-78%3.836-86%3.648-85%
 EOD+4 -4MRQTTM+0 -0YOY+23 -173Y+20 -205Y+23 -1710Y+18 -22

3.3 Fundamental Score

Let's check the fundamental score of Bioqual Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1572.241
Price to Book Ratio (EOD)Between0-10.928
Net Profit Margin (MRQ)Greater than00.008
Operating Margin (MRQ)Greater than00.008
Quick Ratio (MRQ)Greater than13.850
Current Ratio (MRQ)Greater than14.016
Debt to Asset Ratio (MRQ)Less than10.335
Debt to Equity Ratio (MRQ)Less than10.503
Return on Equity (MRQ)Greater than0.150.013
Return on Assets (MRQ)Greater than0.050.009
Total7/10 (70.0%)

3.4 Technical Score

Let's check the technical score of Bioqual Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose40.010
Total1/1 (100.0%)

4. In-depth Analysis

4.1 About Bioqual Inc

Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides animal research model related services. Bioqual, Inc. was founded in 1981 and is based in Rockville, Maryland.

Fundamental data was last updated by Penke on 2025-09-12 00:37:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is not making a profit/loss.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Bioqual earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Bioqual to theΒ Diagnostics & Research industry mean.
  • A Net Profit Margin of 0.8%Β means thatΒ $0.01 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Bioqual Inc:

  • The MRQ is 0.8%. The company is not making a profit/loss.
  • The TTM is 0.8%. The company is not making a profit/loss.
Trends
Current periodCompared to+/- 
MRQ0.8%TTM0.8%0.0%
TTM0.8%YOY1.3%-0.5%
TTM0.8%5Y6.0%-5.2%
5Y6.0%10Y7.4%-1.3%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8%-2.6%+3.4%
TTM0.8%-6.5%+7.3%
YOY1.3%-6.9%+8.2%
3Y3.4%-9.2%+12.6%
5Y6.0%-3.1%+9.1%
10Y7.4%-1.6%+9.0%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Bioqual is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Bioqual to theΒ Diagnostics & Research industry mean.
  • 0.9% Return on Assets means thatΒ Bioqual generatedΒ $0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Bioqual Inc:

  • The MRQ is 0.9%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.9%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.9%TTM0.9%0.0%
TTM0.9%YOY1.4%-0.5%
TTM0.9%5Y6.2%-5.3%
5Y6.2%10Y9.8%-3.6%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9%-0.6%+1.5%
TTM0.9%-1.2%+2.1%
YOY1.4%-1.1%+2.5%
3Y3.5%-1.5%+5.0%
5Y6.2%0.2%+6.0%
10Y9.8%0.2%+9.6%
4.3.1.3. Return on Equity

Shows how efficient Bioqual is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Bioqual to theΒ Diagnostics & Research industry mean.
  • 1.3% Return on Equity means Bioqual generated $0.01Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Bioqual Inc:

  • The MRQ is 1.3%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.3%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ1.3%TTM1.3%0.0%
TTM1.3%YOY2.2%-0.9%
TTM1.3%5Y10.3%-9.0%
5Y10.3%10Y13.4%-3.1%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3%-0.1%+1.4%
TTM1.3%-0.9%+2.2%
YOY2.2%-0.5%+2.7%
3Y5.8%-2.1%+7.9%
5Y10.3%-1.0%+11.3%
10Y13.4%-1.1%+14.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Bioqual Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Bioqual is operatingΒ .

  • Measures how much profit Bioqual makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Bioqual to theΒ Diagnostics & Research industry mean.
  • An Operating Margin of 0.8%Β means the company generated $0.01 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Bioqual Inc:

  • The MRQ is 0.8%. The company is operating inefficient. -1
  • The TTM is 0.8%. The company is operating inefficient. -1
Trends
Current periodCompared to+/- 
MRQ0.8%TTM0.8%0.0%
TTM0.8%YOY1.8%-0.9%
TTM0.8%5Y7.9%-7.0%
5Y7.9%10Y10.7%-2.9%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8%-10.0%+10.8%
TTM0.8%-12.4%+13.2%
YOY1.8%-12.2%+14.0%
3Y4.2%-0.3%+4.5%
5Y7.9%3.0%+4.9%
10Y10.7%2.9%+7.8%
4.3.2.2. Operating Ratio

Measures how efficient Bioqual is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Diagnostics & Research industry mean).
  • An Operation Ratio of 1.00 means that the operating costs are $1.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Bioqual Inc:

  • The MRQ is 1.000. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.000. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.000TTM1.0000.000
TTM1.000YOY0.982+0.018
TTM1.0005Y0.924+0.076
5Y0.92410Y0.895+0.029
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0001.329-0.329
TTM1.0001.318-0.318
YOY0.9821.247-0.265
3Y0.9611.260-0.299
5Y0.9241.229-0.305
10Y0.8951.148-0.253
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Bioqual Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Bioqual is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Diagnostics & Research industry mean).
  • A Current Ratio of 4.02Β means the company has $4.02 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Bioqual Inc:

  • The MRQ is 4.016. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.016. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.016TTM4.0160.000
TTM4.016YOY3.608+0.408
TTM4.0165Y3.547+0.469
5Y3.54710Y4.569-1.022
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ4.0161.969+2.047
TTM4.0162.158+1.858
YOY3.6082.331+1.277
3Y3.6252.421+1.204
5Y3.5472.689+0.858
10Y4.5693.137+1.432
4.4.3.2. Quick Ratio

Measures if Bioqual is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Bioqual to theΒ Diagnostics & Research industry mean.
  • A Quick Ratio of 3.85Β means the company can pay off $3.85 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Bioqual Inc:

  • The MRQ is 3.850. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.850. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.850TTM3.8500.000
TTM3.850YOY3.447+0.403
TTM3.8505Y3.354+0.496
5Y3.35410Y4.427-1.073
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ3.8501.152+2.698
TTM3.8501.229+2.621
YOY3.4471.431+2.016
3Y3.4201.620+1.800
5Y3.3541.808+1.546
10Y4.4272.242+2.185
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Bioqual Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of BioqualΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Bioqual to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.33Β means that Bioqual assets areΒ financed with 33.5% credit (debt) and the remaining percentage (100% - 33.5%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Bioqual Inc:

  • The MRQ is 0.335. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.335. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.335TTM0.3350.000
TTM0.335YOY0.387-0.052
TTM0.3355Y0.386-0.051
5Y0.38610Y0.287+0.099
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3350.401-0.066
TTM0.3350.426-0.091
YOY0.3870.397-0.010
3Y0.3750.389-0.014
5Y0.3860.413-0.027
10Y0.2870.444-0.157
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Bioqual is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Bioqual to theΒ Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 50.3% means that company has $0.50 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Bioqual Inc:

  • The MRQ is 0.503. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.503. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.503TTM0.5030.000
TTM0.503YOY0.630-0.127
TTM0.5035Y0.633-0.130
5Y0.63310Y0.434+0.199
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5030.622-0.119
TTM0.5030.598-0.095
YOY0.6300.621+0.009
3Y0.6050.654-0.049
5Y0.6330.636-0.003
10Y0.4340.660-0.226
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Bioqual generates.

  • Above 15 is considered overpriced butΒ always compareΒ Bioqual to theΒ Diagnostics & Research industry mean.
  • A PE ratio of 134.12 means the investor is paying $134.12Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Bioqual Inc:

  • The EOD is 72.241. Based on the earnings, the company is expensive. -2
  • The MRQ is 134.121. Based on the earnings, the company is expensive. -2
  • The TTM is 134.121. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD72.241MRQ134.121-61.881
MRQ134.121TTM134.1210.000
TTM134.121YOY81.355+52.767
TTM134.1215Y50.305+83.816
5Y50.30510Y27.500+22.805
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD72.241-0.326+72.567
MRQ134.121-0.485+134.606
TTM134.121-0.417+134.538
YOY81.355-0.286+81.641
3Y75.7930.171+75.622
5Y50.3058.019+42.286
10Y27.5007.601+19.899
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Bioqual Inc:

  • The EOD is 3.986. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 7.401. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 7.401. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD3.986MRQ7.401-3.415
MRQ7.401TTM7.4010.000
TTM7.401YOY11.353-3.952
TTM7.4015Y1.006+6.395
5Y1.00610Y4.033-3.027
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD3.9862.334+1.652
MRQ7.4011.916+5.485
TTM7.401-0.027+7.428
YOY11.353-0.640+11.993
3Y1.686-0.287+1.973
5Y1.006-0.302+1.308
10Y4.033-0.255+4.288
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Bioqual is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 1.72 means the investor is paying $1.72Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Bioqual Inc:

  • The EOD is 0.928. Based on the equity, the company is cheap. +2
  • The MRQ is 1.722. Based on the equity, the company is underpriced. +1
  • The TTM is 1.722. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.928MRQ1.722-0.795
MRQ1.722TTM1.7220.000
TTM1.722YOY1.807-0.085
TTM1.7225Y1.852-0.129
5Y1.85210Y1.367+0.485
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD0.9282.215-1.287
MRQ1.7222.044-0.322
TTM1.7222.113-0.391
YOY1.8072.276-0.469
3Y1.7302.478-0.748
5Y1.8523.336-1.484
10Y1.3674.369-3.002
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-05-312021-05-312022-05-312023-05-312024-05-31
Net Debt  5,8891,0106,8999,64216,541-8,6547,887-19,894-12,007
Operating Income  5,3223,2358,557-2,0246,533-5,4301,103-1,123-20
Income Tax Expense  1,2581,0312,289-9731,316-1,019298-305-7



6.2. Latest Balance Sheet

Balance Sheet of 2024-05-31. All numbers in thousands.

Summary
Total Assets56,588
Total Liabilities18,938
Total Stockholder Equity37,650
 As reported
Total Liabilities 18,938
Total Stockholder Equity+ 37,650
Total Assets = 56,588

Assets

Total Assets56,588
Total Current Assets30,874
Long-term Assets25,714
Total Current Assets
Cash And Cash Equivalents 15,594
Net Receivables 14,003
Other Current Assets 1,277
Total Current Assets  (as reported)30,874
Total Current Assets  (calculated)30,874
+/-0
Long-term Assets
Property Plant Equipment 24,662
Goodwill 1,028
Long-term Assets  (as reported)25,714
Long-term Assets  (calculated)25,690
+/- 23

Liabilities & Shareholders' Equity

Total Current Liabilities7,688
Long-term Liabilities11,250
Total Stockholder Equity37,650
Total Current Liabilities
Short-term Debt 3,587
Accounts payable 1,380
Other Current Liabilities 2,275
Total Current Liabilities  (as reported)7,688
Total Current Liabilities  (calculated)7,241
+/- 446
Long-term Liabilities
Long-term Liabilities  (as reported)11,250
Long-term Liabilities  (calculated)0
+/- 11,250
Total Stockholder Equity
Common Stock16
Retained Earnings 31,310
Other Stockholders Equity 6,324
Total Stockholder Equity (as reported)37,650
Total Stockholder Equity (calculated)37,650
+/-0
Other
Cash and Short Term Investments 15,594
Common Stock Shares Outstanding 894
Current Deferred Revenue446
Liabilities and Stockholders Equity 56,588
Net Debt -12,007
Net Working Capital 23,187
Short Long Term Debt Total 3,587



6.3. Balance Sheets Structured

All numbers in thousands.

 Trend2024-05-312023-05-312022-05-312021-05-312020-05-312019-05-312018-05-312017-05-312016-05-312015-05-312014-05-312013-05-312011-05-312010-05-312007-05-312006-05-312005-05-312004-05-312003-05-312001-05-312000-05-311999-05-311998-05-311997-05-311996-05-31
> Total Assets 
4,231
4,695
4,277
4,624
5,326
4,874
5,968
7,622
9,162
8,688
10,152
12,233
13,297
11,790
15,477
17,363
19,427
22,760
26,305
28,310
49,548
53,420
63,342
61,317
56,588
56,58861,31763,34253,42049,54828,31026,30522,76019,42717,36315,47711,79013,29712,23310,1528,6889,1627,6225,9684,8745,3264,6244,2774,6954,231
   > Total Current Assets 
1,972
2,128
1,798
1,814
2,480
2,256
3,293
3,955
5,246
4,947
6,153
8,545
9,979
9,498
9,688
12,133
14,596
17,901
20,253
21,271
26,255
29,322
31,728
29,940
30,874
30,87429,94031,72829,32226,25521,27120,25317,90114,59612,1339,6889,4989,9798,5456,1534,9475,2463,9553,2932,2562,4801,8141,7982,1281,972
       Cash And Cash Equivalents 
219
63
66
69
72
76
526
79
1,228
2,251
2,794
3,153
2,719
4,844
1,978
3,709
5,178
9,288
10,161
9,208
10,256
7,720
2,184
7,279
15,594
15,5947,2792,1847,72010,2569,20810,1619,2885,1783,7091,9784,8442,7193,1532,7942,2511,228795267672696663219
       Net Receivables 
1,580
1,894
1,589
1,289
1,970
1,739
2,424
3,492
3,872
2,514
2,894
5,218
7,112
4,064
7,436
8,307
9,323
8,354
9,693
11,529
14,638
20,108
26,764
21,318
14,003
14,00321,31826,76420,10814,63811,5299,6938,3549,3238,3077,4364,0647,1125,2182,8942,5143,8723,4922,4241,7391,9701,2891,5891,8941,580
       Inventory 
53
45
45
288
226
181
39
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000039181226288454553
       Other Current Assets 
120
126
99
169
212
260
304
384
146
181
464
174
148
591
273
556
96
258
400
634
1,549
1,494
2,780
1,343
1,277
1,2771,3432,7801,4941,5496344002589655627359114817446418114638430426021216999126120
   > Long-term Assets 
2,259
2,566
2,479
2,810
2,846
2,618
2,675
3,667
3,916
3,741
4,000
3,689
3,318
2,292
5,789
5,231
4,831
4,859
6,051
7,039
23,293
24,098
31,614
31,377
25,714
25,71431,37731,61424,09823,2937,0396,0514,8594,8315,2315,7892,2923,3183,6894,0003,7413,9163,6672,6752,6182,8462,8102,4792,5662,259
       Property Plant Equipment 
1,270
1,474
1,492
1,473
1,607
1,413
2,238
3,168
3,362
3,136
3,344
2,895
2,482
1,268
3,421
2,986
2,821
2,948
4,288
5,294
21,496
22,958
30,586
30,349
24,662
24,66230,34930,58622,95821,4965,2944,2882,9482,8212,9863,4211,2682,4822,8953,3443,1363,3623,1682,2381,4131,6071,4731,4921,4741,270
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,028
1,0281,0281,0281,0281,0281,0281,0281,0281,0281,0281,02800000000000000
       Long Term Investments 
0
0
0
494
441
664
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000664441494000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
237
91
47
37
26
16
6
0
0
0
0
00006162637479123700000000000000
       Long-term Assets Other 
192
295
324
736
741
1,006
437
499
553
605
656
794
836
1,024
1,102
1,125
934
770
708
701
763
112
-31,614
-31,377
0
0-31,377-31,6141127637017087709341,1251,1021,0248367946566055534994371,006741736324295192
> Total Liabilities 
927
1,386
1,119
1,128
1,758
1,045
1,216
2,116
2,922
2,041
2,510
2,070
2,924
1,448
4,415
4,574
4,073
3,845
4,255
3,746
21,366
19,890
25,670
23,703
18,938
18,93823,70325,67019,89021,3663,7464,2553,8454,0734,5744,4151,4482,9242,0702,5102,0412,9222,1161,2161,0451,7581,1281,1191,386927
   > Total Current Liabilities 
639
1,222
996
1,071
1,568
962
1,070
1,666
2,392
1,573
2,181
1,491
2,477
1,448
2,524
3,091
3,072
3,100
3,464
2,777
7,682
8,517
9,765
8,297
7,688
7,6888,2979,7658,5177,6822,7773,4643,1003,0723,0912,5241,4482,4771,4912,1811,5732,3921,6661,0709621,5681,0719961,222639
       Short-term Debt 
114
660
353
341
811
302
0
0
0
0
0
0
0
0
276
289
303
317
250
-270
2,874
3,303
3,071
3,442
3,587
3,5873,4423,0713,3032,874-27025031730328927600000000302811341353660114
       Short Long Term Debt 
0
0
0
341
811
302
0
0
0
0
0
0
0
0
1,435
289
303
317
250
0
0
0
0
0
0
0000002503173032891,43500000000302811341000
       Accounts payable 
234
251
234
216
201
168
234
240
321
569
409
401
599
313
618
807
1,222
1,241
1,804
1,312
2,476
2,108
3,289
1,594
1,380
1,3801,5943,2892,1082,4761,3121,8041,2411,222807618313599401409569321240234168201216234251234
       Other Current Liabilities 
287
306
396
490
555
492
809
1,420
1,774
1,004
1,627
931
912
1,134
1,630
2,190
1,426
1,332
1,045
1,465
1,504
2,231
2,240
2,304
2,275
2,2752,3042,2402,2311,5041,4651,0451,3321,4262,1901,6301,1349129311,6271,0041,7741,420809492555490396306287
   > Long-term Liabilities 
288
164
122
56
190
83
146
450
530
467
330
579
447
0
1,891
1,483
1,001
745
791
969
13,684
11,373
15,905
15,406
11,250
11,25015,40615,90511,37313,6849697917451,0011,4831,89104475793304675304501468319056122164288
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
733
613
434
495
791
969
413
58
251
240
0
02402515841396979149543461373300000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
370
531
0
0
0
0
0
0
0
00000005313700000000000000000
> Total Stockholder Equity
3,304
3,308
3,158
3,496
3,568
3,829
4,752
5,506
6,240
6,648
7,642
10,163
10,373
10,194
11,062
12,789
15,354
18,915
22,050
24,564
28,182
33,530
37,672
37,614
37,650
37,65037,61437,67233,53028,18224,56422,05018,91515,35412,78911,06210,19410,37310,1637,6426,6486,2405,5064,7523,8293,5683,4963,1583,3083,304
   Common Stock
96
96
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16
16161616161616161616161616161616161616161616169696
   Retained Earnings 
-3,560
-3,556
-3,705
-3,310
-3,230
-2,971
-1,971
-1,286
-501
282
1,260
3,800
4,058
3,892
4,760
6,488
9,054
12,615
15,741
18,242
21,847
27,190
31,333
31,274
31,310
31,31031,27431,33327,19021,84718,24215,74112,6159,0546,4884,7603,8924,0583,8001,260282-501-1,286-1,971-2,971-3,230-3,310-3,705-3,556-3,560
   Capital Surplus 0000000000000000000000000
   Treasury Stock0000000000000000000-692-6930000
   Other Stockholders Equity 
6,768
6,768
6,847
6,790
6,782
6,785
6,707
6,776
6,725
6,350
6,366
6,347
6,299
6,285
6,285
6,285
6,284
6,284
6,293
6,306
6,319
6,324
6,324
6,324
6,324
6,3246,3246,3246,3246,3196,3066,2936,2846,2846,2856,2856,2856,2996,3476,3666,3506,7256,7766,7076,7856,7826,7906,8476,7686,768



6.4. Balance Sheets

All numbers in thousands.




6.5. Cash Flows

All numbers in thousands.




6.6. Income Statements

All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2024-05-31. All numbers in thousands.

Gross Profit (+$)
totalRevenue58,591
Cost of Revenue-51,162
Gross Profit7,4297,429
 
Operating Income (+$)
Gross Profit7,429
Operating Expense-7,449
Operating Income-20-20
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense7,4490
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-20
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)476-516
EBIT - interestExpense = 476
476
483
Interest Expense0
Earnings Before Interest and Taxes (EBIT)476476
Earnings Before Interest and Taxes (EBITDA)3,032
 
After tax Income (+$)
Income Before Tax476
Tax Provision-0
Net Income From Continuing Ops0476
Net Income483
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses58,115
Total Other Income/Expenses Net4960
 

Technical Analysis of Bioqual
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Bioqual. The general trend of Bioqual is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Bioqual's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Bioqual Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Bioqual Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 43.19 < 43.19 < 43.19.

The bearish price targets are: .

Know someone who trades $BIOQ? Share this with them.πŸ‘‡

Bioqual Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Bioqual Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Bioqual Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Bioqual Inc.

Bioqual Inc Daily Moving Average Convergence/Divergence (MACD) ChartBioqual Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Bioqual Inc. The current adx is .

Bioqual Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Bioqual Inc.

Bioqual Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Bioqual Inc.

Bioqual Inc Daily Relative Strength Index (RSI) ChartBioqual Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Bioqual Inc.

Bioqual Inc Daily Stochastic Oscillator ChartBioqual Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Bioqual Inc.

Bioqual Inc Daily Commodity Channel Index (CCI) ChartBioqual Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Bioqual Inc.

Bioqual Inc Daily Chande Momentum Oscillator (CMO) ChartBioqual Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Bioqual Inc.

Bioqual Inc Daily Williams %R ChartBioqual Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Bioqual Inc.

Bioqual Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Bioqual Inc.

Bioqual Inc Daily Average True Range (ATR) ChartBioqual Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Bioqual Inc.

Bioqual Inc Daily On-Balance Volume (OBV) ChartBioqual Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Bioqual Inc.

Bioqual Inc Daily Money Flow Index (MFI) ChartBioqual Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Bioqual Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-04-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-12ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-14ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-15ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-06-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-10ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-09-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-09-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Bioqual Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Bioqual Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose40.010
Total1/1 (100.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Bioqual with someone you think should read this too:
  • Are you bullish or bearish on Bioqual? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Bioqual? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Bioqual Inc

I send you an email if I find something interesting about Bioqual Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Bioqual Inc.

Receive notifications about Bioqual Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.